BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27929428)

  • 1. HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin.
    Ruggeri RM; Campennì A; Giuffrè G; Giovanella L; Siracusa M; Simone A; Branca G; Scarfì R; Trimarchi F; Ieni A; Tuccari G
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.
    Sugishita Y; Kammori M; Yamada O; Poon SS; Kobayashi M; Onoda N; Yamazaki K; Fukumori T; Yoshikawa K; Onose H; Ishii S; Yamada E; Yamada T
    Int J Oncol; 2013 May; 42(5):1589-96. PubMed ID: 23467725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.
    Kremser R; Obrist P; Spizzo G; Erler H; Kendler D; Kemmler G; Mikuz G; Ensinger C
    Virchows Arch; 2003 Apr; 442(4):322-8. PubMed ID: 12715168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.
    Caria P; Cantara S; Frau DV; Pacini F; Vanni R; Dettori T
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
    Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
    Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy.
    Bechmann T; Olsen DA; Jakobsen EH; Madsen JS; Brandslund I; Jylling AM; Steffensen KD; Jakobsen A
    Oncol Rep; 2013 Apr; 29(4):1475-82. PubMed ID: 23417164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
    Kavanagh DO; McIlroy M; Myers E; Bane F; Crotty TB; McDermott E; Hill AD; Young LS
    Endocr Relat Cancer; 2010 Mar; 17(1):255-64. PubMed ID: 20032008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.
    Brownlie B; Mercer P; Turner J; Allison R
    N Z Med J; 2008 Aug; 121(1279):36-45. PubMed ID: 18709046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
    Al-Saad S; Al-Shibli K; Donnem T; Andersen S; Bremnes RM; Busund LT
    J Thorac Oncol; 2010 Oct; 5(10):1536-43. PubMed ID: 20802349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
    Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
    Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
    Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
    Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunohistochemistry with fluorescence in situ hybridization in determining the human epidermal growth factor receptor 2 status of breast cancer specimens: a multicenter study of 3,149 Chinese patients.
    Han X; Shi Y; Ma L; Lyu Z; Yang H; Yao J; Li J; Li B; Qin Y
    Chin Med J (Engl); 2014; 127(2):246-53. PubMed ID: 24438611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.
    Im SA; Kim JW; Kim JS; Kim MA; Jordan B; Pickl M; Han SW; Oh DY; Lee HJ; Kim TY; Kim WH; Yang HK; Bang YJ
    Diagn Mol Pathol; 2011 Jun; 20(2):94-100. PubMed ID: 21532492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.
    Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
    Anticancer Res; 2003; 23(3B):2349-53. PubMed ID: 12894514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH).
    Hwang HC; Gown AM
    Methods Mol Biol; 2016; 1406():61-70. PubMed ID: 26820945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.